Lipoxygenase catalyzed metabolites derived from docosahexaenoic acid are promising antitumor agents against breast cancer
Abstract Docosahexaenoic acid (DHA) is known to inhibit breast cancer in the rat. Here we investigated whether DHA itself or select metabolites can account for its antitumor action. We focused on metabolites derived from the lipoxygenase (LOX) pathway since we previously showed that they were superi...
Guardado en:
Autores principales: | Kun-Ming Chen, Henry Thompson, John P. Vanden-Heuvel, Yuan-Wan Sun, Neil Trushin, Cesar Aliaga, Krishne Gowda, Shantu Amin, Bruce Stanley, Andrea Manni, Karam El-Bayoumy |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c4bb46a811624f08af671d39c0e3ef81 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
15-Lipoxygenase and its metabolites in the pathogenesis of breast cancer: A double-edged sword
por: Mohammad Amin Vaezi, et al.
Publicado: (2021) -
Endogenous metabolites of vitamin E limit inflammation by targeting 5-lipoxygenase
por: Helmut Pein, et al.
Publicado: (2018) -
Catalyzed Synthesis of Zinc Clays by Prebiotic Central Metabolites
por: Ruixin Zhou, et al.
Publicado: (2017) -
Erratum: Catalyzed Synthesis of Zinc Clays by Prebiotic Central Metabolites
por: Ruixin Zhou, et al.
Publicado: (2017) -
Paralog- and ortholog-specificity of inhibitors of human and mouse lipoxygenase-isoforms
por: Kumar Reddy Kakularam, et al.
Publicado: (2022)